After years of research and development, US grocery retailer Safeway is rolling out its own vaccine in the face of a spike in coronavirus cases in the US.

The new vaccine is not an all-or-nothing product that is required to receive a US flu vaccination, nor is it an alternative to a flu vaccine.

Instead, it is designed to provide a better response than the current vaccine.

The vaccine is being tested by Safeway in several locations around the country, including locations in Kansas City, Missouri, and New York City.

“We’re very happy with the results and it’s really helping us to stay ahead of the curve,” said Safeway spokeswoman Jennifer Smith.

The new vaccine will be offered in a two-dose series starting in November.

That will be the first time that a vaccine has been available in an all or nothing vaccine, since the vaccine was initially developed by Pfizer back in 2005.

The initial study was conducted by a team led by researchers from the Johns Hopkins Bloomberg School of Public Health and the Johns Bloomberg School at Columbia University.

The second study was led by the Vaccine Research Institute of Columbia University and conducted by researchers at Johns Hopkins University and the University of California, Berkeley.

Smith said that the vaccine is designed for people who have not received the flu vaccine before and have not had a flu-like illness in the past 12 months.

That means people who had flu symptoms and who are currently receiving a flu shot could benefit from the new vaccine.

“This is a vaccine that is designed specifically to be given to those people,” Smith said.

“It’s not going to be designed for everybody who has had flu or who hasn’t had flu in the last 12 months, but it will help people who are getting flu.”

The vaccine will provide an 80% chance of preventing an infection with coronaviruses.

A full flu vaccine contains the same amount of vaccine.

However, people who do not have the flu can receive up to two doses of the vaccine, which provides the same protection.

A second study is currently underway in the United Kingdom, where a trial of the new flu vaccine is currently being conducted.

The first phase of the study was recently completed in England and Wales.

The second phase of that trial is set to begin in March and will examine the safety and effectiveness of the flu vaccination program in England.

Safeway is currently selling two doses, with the first being available in November at its store locations and stores nationwide.

In addition to the flu shot, Safeway has also offered free flu vaccines to people who can afford to pay for them.

Smith said that this program has been successful in encouraging people to pay.